OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Narrative Review of COVID-19 Vaccines
Barbaros Eroglu, Rina Fajri Nuwarda, Iqbal Ramzan, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 62-62
Open Access | Times Cited: 54
Barbaros Eroglu, Rina Fajri Nuwarda, Iqbal Ramzan, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 62-62
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis
Muhammad Mainuddin Patwary, Md Ashraful Alam, Mondira Bardhan, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 427-427
Open Access | Times Cited: 118
Muhammad Mainuddin Patwary, Md Ashraful Alam, Mondira Bardhan, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 427-427
Open Access | Times Cited: 118
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 759-759
Open Access | Times Cited: 55
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 759-759
Open Access | Times Cited: 55
COVID-19 Vaccines: Current and Future Perspectives
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
Perception of COVID-19 Booster Dose Vaccine among Healthcare Workers in India and Saudi Arabia
Sajith Vellappally, Sachin Naik, Omar Alsadon, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 8942-8942
Open Access | Times Cited: 33
Sajith Vellappally, Sachin Naik, Omar Alsadon, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 8942-8942
Open Access | Times Cited: 33
Recombinant vaccines in 2022: a perspective from the cell factory
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Peptide and m-RNA Vaccines: Peculiarities of Immunogenicity and Protective Effect
Т. Ф. Степанова, О. Е. Троценко, I. V. Bakshtanovskaya, et al.
Epidemiology and Vaccinal Prevention (2025) Vol. 23, Iss. 6, pp. 137-146
Open Access
Т. Ф. Степанова, О. Е. Троценко, I. V. Bakshtanovskaya, et al.
Epidemiology and Vaccinal Prevention (2025) Vol. 23, Iss. 6, pp. 137-146
Open Access
Discovering symptom patterns of COVID-19 vaccine adverse reactions using association rule mining
Hind Monadhel, Ayad R. Abbas, Athraa Jasim Mohammed
AIP conference proceedings (2025) Vol. 3224, pp. 030034-030034
Closed Access
Hind Monadhel, Ayad R. Abbas, Athraa Jasim Mohammed
AIP conference proceedings (2025) Vol. 3224, pp. 030034-030034
Closed Access
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
COVID-19 vaccine design and vaccination strategy for emerging variants
Vivek P. Chavda, Vasso Apostolopoulos
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1359-1361
Closed Access | Times Cited: 20
Vivek P. Chavda, Vasso Apostolopoulos
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1359-1361
Closed Access | Times Cited: 20
Planning and Organization of the COVID-19 Vaccination Campaign: An Overview of Eight European Countries
Chiara Cadeddu, Aldo Rosano, Leonardo Villani, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1631-1631
Open Access | Times Cited: 14
Chiara Cadeddu, Aldo Rosano, Leonardo Villani, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1631-1631
Open Access | Times Cited: 14
Exploring the experience of developing COVID-19 vaccines in Iran
Mostafa Ghanei, Ali Mohabattalab, Kiarash Fartash, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 1, pp. 1-1
Open Access | Times Cited: 8
Mostafa Ghanei, Ali Mohabattalab, Kiarash Fartash, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 1, pp. 1-1
Open Access | Times Cited: 8
Shedding light on the toxicity of SARS-CoV-2-derived peptide in non-target COVID-19 organisms: A study involving inbred and outbred mice
Thiarlen Marinho da Luz, Amanda Pereira da Costa Araújo, Fernanda Neves Estrêla Rezende, et al.
NeuroToxicology (2022) Vol. 90, pp. 184-196
Open Access | Times Cited: 12
Thiarlen Marinho da Luz, Amanda Pereira da Costa Araújo, Fernanda Neves Estrêla Rezende, et al.
NeuroToxicology (2022) Vol. 90, pp. 184-196
Open Access | Times Cited: 12
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy
Giovanni Corrao, Matteo Franchi, Danilo Cereda, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Giovanni Corrao, Matteo Franchi, Danilo Cereda, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Vaccines Against COVID-19: A Review
Carlos U. Torres-Estrella, María del Roció Reyes-Montes, Esperanza Duarte-Escalante, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 414-414
Open Access | Times Cited: 11
Carlos U. Torres-Estrella, María del Roció Reyes-Montes, Esperanza Duarte-Escalante, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 414-414
Open Access | Times Cited: 11
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
Christopher A. MacRaild, Muzaffar-Ur-Rehman Mohammed, Faheem Faheem, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11851-11851
Open Access | Times Cited: 10
Christopher A. MacRaild, Muzaffar-Ur-Rehman Mohammed, Faheem Faheem, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11851-11851
Open Access | Times Cited: 10
A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
Gan Zhao, Zhiyu Zhang, Yuan Ding, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 513-513
Open Access | Times Cited: 5
Gan Zhao, Zhiyu Zhang, Yuan Ding, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 513-513
Open Access | Times Cited: 5
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial
Yuzhou Gui, Ye Cao, Jiajin He, et al.
Life Metabolism (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 5
Yuzhou Gui, Ye Cao, Jiajin He, et al.
Life Metabolism (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 5
Benjamin M. Kagina, Carine Dochez
Respirology (2022) Vol. 27, Iss. 4, pp. 260-261
Open Access | Times Cited: 9
Trusted information sources in the early months of the COVID-19 pandemic predict vaccination uptake over one year later
Carl A. Latkin, Lauren Dayton, Jacob Miller, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 573-580
Open Access | Times Cited: 9
Carl A. Latkin, Lauren Dayton, Jacob Miller, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 573-580
Open Access | Times Cited: 9
Visual Analysis on Ferroptosis and its Cross-talk to Coronavirus Disease 2019 (COVID-19)
Junda Zhou, Wenjia Ni, Xianqin Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37617-e37617
Open Access | Times Cited: 1
Junda Zhou, Wenjia Ni, Xianqin Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37617-e37617
Open Access | Times Cited: 1
Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
Matthew D. Resch, Ke Wen, Ryan Mazboudi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1997-1997
Open Access | Times Cited: 8
Matthew D. Resch, Ke Wen, Ryan Mazboudi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1997-1997
Open Access | Times Cited: 8
Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study
Romana Hosain, Peter Aquino, Carmen Baccarini, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2253-2260
Open Access | Times Cited: 4
Romana Hosain, Peter Aquino, Carmen Baccarini, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2253-2260
Open Access | Times Cited: 4
What we talk about when we talk about COVID-19 vaccination campaign impact: a narrative review
Horácio Nelson Hastenreiter Filho, Igor Tona Peres, Lucas Maddalena, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Horácio Nelson Hastenreiter Filho, Igor Tona Peres, Lucas Maddalena, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Prevalence of Post COVID-19 Condition among Healthcare Workers: Self-Reported Online Survey in Four African Countries, December 2021–January 2022
Hager Elnadi, Ahmad Ibrahim Al‐Mustapha, Ismail Ayoade Odetokun, et al.
COVID (2023) Vol. 3, Iss. 11, pp. 1663-1676
Open Access | Times Cited: 3
Hager Elnadi, Ahmad Ibrahim Al‐Mustapha, Ismail Ayoade Odetokun, et al.
COVID (2023) Vol. 3, Iss. 11, pp. 1663-1676
Open Access | Times Cited: 3
